## IVZ: Invesco Ltd. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -1.6% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.9% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($25.18)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Invesco SteelPath MLP Alpha Fund Q3 2025 Commentary (Mutual Fund:MLPAX)**
- Source: Seeking Alpha | 20251230T120812 | Somewhat-Bullish | Relevance: 100%
- The Invesco SteelPath MLP Alpha Fund's Q3 2025 commentary highlights that Master Limited Partnerships (MLPs) underperformed the broader equity market, with the Alerian MLP Index losing 3.04% on a price basis. Despite this, the midstream sector saw 62% of participants report strong Q2 results, attributed to attractive valuations leading to stock buybacks and increasing natural gas demand from AI data centers. The fund believes the midstream sector offers attractive distribution yields and improving cash flow and distribution growth prospects.

**2. Invesco QQQ $QQQ is Encompass More Asset Management's 5th Largest Position**
- Source: MarketBeat | 20251229T101945 | Neutral | Relevance: 95%
- Encompass More Asset Management recently reduced its stake in Invesco QQQ (NASDAQ:QQQ) by 14.2%, making it still their 5th largest position. Several other institutional investors have increased their holdings in the ETF, while the stock currently trades at $623.89 and has a 0.5% annualized dividend yield. The article also touches on mixed sentiment regarding QQQ's future, with positive views on tech ETFs for 2026 and negative sentiment concerning potential valuation risks and market rotation to value stocks.

**3. Armbruster Capital Management Inc. Boosts Stake in Invesco S&P SmallCap Low Volatility ETF $XSLV**
- Source: Defense World | 20251230T090844 | Neutral | Relevance: 65%
- Armbruster Capital Management Inc. increased its holdings in the Invesco S&P SmallCap Low Volatility ETF (XSLV) by 6.4% in the third quarter, making it their 15th biggest holding. The firm now owns 237,575 shares valued at $11,002,000. Other institutional investors like Laurel Wealth Advisors LLC, Jane Street Group LLC, and Invesco Ltd. also adjusted their stakes in XSLV.

**4. Sapient Capital LLC Sells 8,077 Shares of Gilead Sciences, Inc. $GILD**
- Source: MarketBeat | 20251228T121915 | Neutral | Relevance: 65%
- Sapient Capital LLC significantly reduced its stake in Gilead Sciences, selling 8,077 shares and bringing its total holdings to 175,078 shares valued at $19.7 million. This comes as Gilead Sciences reported strong Q3 earnings, beating analyst estimates and issuing optimistic FY2025 EPS guidance. While institutional investors like Norges Bank and Ameriprise Financial increased their positions, corporate insiders have been net sellers of the company's stock.

**5. Principal Financial Group, Inc. $PFG Stake Boosted by HBK Sorce Advisory LLC**
- Source: MarketBeat | 20251230T105642 | Neutral | Relevance: 64%
- HBK Sorce Advisory LLC significantly increased its holdings in Principal Financial Group (NYSE:PFG) by 481.3% in the third quarter, bringing its total to 15,241 shares valued at $1.25 million. Major institutional investors collectively own about 75.08% of the stock. Principal Financial Group recently surpassed its quarterly EPS estimate, raised its dividend, and maintains a "Hold" consensus rating with a $90.70 price target.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 4, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $28 | $27 | +4% |
| 2025-12-17 | Deutsche Bank | $31 | $26 | +19% |
| 2025-12-12 | Barclays | $28 | $25 | +12% |
| 2025-12-10 | BMO Capital | $30 | $28 | +7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Equal-Weight |
| 2025-12-17 | Deutsche Bank | up | Buy |
| 2025-12-12 | Barclays | main | Equal-Weight |
| 2025-12-10 | BMO Capital | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 4 ($2.25M) |
| Sells | 4 ($4.39M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 60.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 3 |

**Top Holders:**
- Massachusetts Mutual: 18.3% (0.0%)
- Vanguard Group Inc: 11.7% (+1.1%)
- Blackrock Inc.: 8.5% (-16.7%)
- State Street Corpora: 4.8% (-3.3%)
- Dimensional Fund Adv: 4.8% (+1.5%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-1.9% 5d) with bearish MACD, trend may be turning.
2. Insider selling cluster: $4.4M in recent transactions.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- Analyst target momentum: 4 raises (avg +11%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.46 indicates undervaluation relative to growth. Forward P/E 10.5x attractive for 27% earnings growth. Quality metrics strong (margin 17%). Analyst sentiment positive (4 raises, avg +11%). Institutional flow bullish (5 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.8B |
| Beta | 1.64 |
| 52W Range | $11.60 - $27.48 |
| Short Interest | 5.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.46 |
| Forward P/E | 10.5 |
| Current P/E | 13.4 |
| YoY Growth | 27.1% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 0.3% to -1.6% (-1.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.6pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 57. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.60% (CS: 18) | Neutral |
| RSI_14 | 56.9 | Neutral |
| MACD Histogram | -0.07 | Bearish |
| vs SMA20 | 1.005x | Above |
| vs SMA50 | 1.074x | Above |
| vs SMA200 | 1.348x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $26.46
- **Stop Loss:** $25.18 (4.8% risk)
- **Target:** $27.74 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 644
- **Position Value:** $17,040.24
- **Portfolio %:** 17.04%
- **Risk Dollars:** $825.00
- **Risk Per Trade:** 0.83%
- **Modifiers:** L1 110% | L2 75% | Combined 0.83x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-01-27 (Est: $0.57)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.44 | $0.61 | +37.7% |
| 2025Q2 | $0.40 | $0.36 | -10.7% |
| 2025Q1 | $0.39 | $0.44 | +13.9% |
| 2024Q4 | $0.47 | $0.52 | +9.6% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*